1 Torre LA,Bray F,Siegel RL,et al.Global cancer statistics 2012[J].CA Cancer J Clin,2015,65(2):87-108. 2 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. 3 Wakahara T,Ueno N,Maeda T,et al.Is the glasgow prognostic score applicable to both early- and advanced-stage gastric cancers?[J].Gastroenterology Res,2017,10(6):359-365. 4 Min KW,Kwon MJ,Kim DH,et al.Persistent elevation of postoperative neutrophil-to-lymphocyte ratio:A better predictor of survival in gastric cancer than elevated preoperative neutrophil-to-lymphocyte ratio[J].Sci Rep,2017,7(1):13967. 5 Chen XD,Mao CC,Wu RS,et al.Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer[J].PLoS One,2017,12(4):e0175074. 6 Coffelt SB,de Visser KE.Cancer:Inflammation lights the way to metastasis[J].Nature,2014,507(7490):48-49. 7 Grivennikov SI,Greten FR,Karin M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899. 8 Urabe M,Yamashita H,Seto Y.Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in patients with resectable gastroesophageal junction and gastric cancer[J].Ann Surg,2017,266(6):76-77. 9 Gonda K,Shibata M,Sato Y,et al.Elevated neutrophil-to-lymphocyte ratio is associated with nutritional impairment,immune suppression,resistance to S-1 plus cisplatin,and poor prognosis in patients with stage IV gastric cancer[J].Mol Clin Oncol,2017,7(6):1073-1078. 10 Xu Z,Xu W,Cheng H,et al.The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer:A Meta-Analysis[J].PLoS One,2016,11(9):e0163719. 11 Zhang CX,Wang SY,Chen SQ,et al.Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features:a meta-analysis[J].Onco Targets Ther,2016,9:3883-3891. 12 Templeton AJ,McNamara MG,Seruga B,et al.Prognostic role of neutrophil- to-lymphocyte ratio in solid tumors:a systematic review and meta-analysis[J].J Natl Cancer Inst,2014,106(6):124. 13 Miyamoto R,Inagawa S,Sano N,et al.The neutrophil-to-lymphocyte ratio(NLR)predicts short-term and long-term outcomes in gastric cancer patients[J].Eur J Surg Oncol,2018,7983(18):30296-30298. 14 Aldemir MN,Turkeli M,Simsek M,et al.Prognostic value of baseline neutrophil-lymphocyte and platelet-lymphocyte ratios in local and advanced gastric cancer patients[J].Asian Pac J Cancer Prev,2015,16(14):5933-5937. 15 Aliustaoglu M,Bilici A,Ustalioglu BB,et al.The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment[J].Med Oncol,2010,27(4):1060-1065. 16 Lou N,Zhang L,Chen XD,et al.A novel scoring system associating with preoperative platelet/lymphocyte and clinicopathologic features to predict lymph node metastasis in early gastric cancer[J].J Surg Res,2017,209:153-161. 17 Namikawa T,Munekage E,Munekage M,et al.Evaluation of systemic inflammatory response biomarkers in patients receiving chemotherapy for unresectable and recurrent advanced gastric cancer[J].Oncology,2016,90(6):321-326. 18 Liu X,Chen S,Liu J,et al.Impact of systemic inflammation on gastric cancer outcomes[J].PLoS One,2017,12(3):e0174085. |